Company Description
Zogenix is intent on alleviating that nasty migraine of yours. The biopharmaceutical company is focused on developing and commercializing central...
Key Zogenix Financials
| Company Type | Private - NASDAQ (GM): ZGNX Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.0 |
| 2007 Employees | 27 |
More Zogenix Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Zogenix's competition across multiple industries
Top Zogenix Competitors
Sponsored Links
The Business Directory
Zogenix Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| VP Business Development | Jonathan M. Rigby | Network | E-mail |
| CEO and Director | Roger L. Hawley | Network | E-mail |
| EVP, CFO, Secretary, and Treasurer | David W. Nassif | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Zogenix News
- Biz360 Secures $10 Million in Funding to Expand Product Line and Boost Marketing & Sales Personnel [Market Wire] (08 May 2008 06:00:00 EDT)
- = CFA IPO: Calendar Of Registrations With The SEC [OsterDowJones Select] (25 Apr 2008 15:00:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.